These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35012660)

  • 1. Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways.
    Charrier M; Lorant J; Contreras-Lopez R; Téjédor G; Blanquart C; Lieubeau B; Schleder C; Leroux I; Deshayes S; Fonteneau JF; Babarit C; Hamel A; Magot A; Péréon Y; Viau S; Delorme B; Luz-Crawford P; Lamirault G; Djouad F; Rouger K
    Stem Cell Res Ther; 2022 Jan; 13(1):7. PubMed ID: 35012660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches.
    Saury C; Lardenois A; Schleder C; Leroux I; Lieubeau B; David L; Charrier M; Guével L; Viau S; Delorme B; Rouger K
    Stem Cell Res Ther; 2018 May; 9(1):128. PubMed ID: 29720259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human fetal liver MSCs are more effective than adult bone marrow MSCs for their immunosuppressive, immunomodulatory, and Foxp3
    Yu Y; Valderrama AV; Han Z; Uzan G; Naserian S; Oberlin E
    Stem Cell Res Ther; 2021 Feb; 12(1):138. PubMed ID: 33597011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells.
    Castro-Manrreza ME; Mayani H; Monroy-García A; Flores-Figueroa E; Chávez-Rueda K; Legorreta-Haquet V; Santiago-Osorio E; Montesinos JJ
    Stem Cells Dev; 2014 Jun; 23(11):1217-32. PubMed ID: 24428376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem/Stromal Cells Derived from Dental Tissues: A Comparative In Vitro Evaluation of Their Immunoregulatory Properties Against T cells.
    De la Rosa-Ruiz MDP; Álvarez-Pérez MA; Cortés-Morales VA; Monroy-García A; Mayani H; Fragoso-González G; Caballero-Chacón S; Diaz D; Candanedo-González F; Montesinos JJ
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis.
    Fu QL; Chow YY; Sun SJ; Zeng QX; Li HB; Shi JB; Sun YQ; Wen W; Tse HF; Lian Q; Xu G
    Allergy; 2012 Oct; 67(10):1215-22. PubMed ID: 22882409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.
    Lorant J; Saury C; Schleder C; Robriquet F; Lieubeau B; Négroni E; Leroux I; Chabrand L; Viau S; Babarit C; Ledevin M; Dubreil L; Hamel A; Magot A; Thorin C; Guevel L; Delorme B; Péréon Y; Butler-Browne G; Mouly V; Rouger K
    Mol Ther; 2018 Feb; 26(2):618-633. PubMed ID: 29221805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
    Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
    Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.
    Li X; Bai J; Ji X; Li R; Xuan Y; Wang Y
    Int J Mol Med; 2014 Sep; 34(3):695-704. PubMed ID: 24970492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems.
    Demircan PC; Sariboyaci AE; Unal ZS; Gacar G; Subasi C; Karaoz E
    Cytotherapy; 2011 Nov; 13(10):1205-20. PubMed ID: 21905956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.
    Mrahleh MA; Matar S; Jafar H; Wehaibi S; Aslam N; Awidi A
    Front Immunol; 2021; 12():732549. PubMed ID: 34650558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.
    Hegyi B; Kudlik G; Monostori E; Uher F
    Biochem Biophys Res Commun; 2012 Mar; 419(2):215-20. PubMed ID: 22333568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human MuStem cells are competent to fuse with nonhuman primate myofibers in a clinically relevant transplantation context: A proof-of-concept study.
    Charrier M; Leroux I; Pichon J; Schleder C; Larcher T; Hamel A; Magot A; Péréon Y; Lamirault G; Tremblay JP; Skuk D; Rouger K
    J Neuropathol Exp Neurol; 2024 Aug; 83(8):684-694. PubMed ID: 38752570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7‑H1‑mediated immunosuppressive properties in human mesenchymal stem cells are mediated by STAT‑1 and not PI3K/Akt signaling.
    Jang IK; Jung HJ; Noh OK; Lee DH; Lee KC; Park JE
    Mol Med Rep; 2018 Aug; 18(2):1842-1848. PubMed ID: 29901104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro.
    Connard SS; Linardi RL; Even KM; Berglund AK; Schnabel LV; Ortved KF
    Vet Immunol Immunopathol; 2021 Apr; 234():110203. PubMed ID: 33636546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells Modified with Heme Oxygenase-1 Have Enhanced Paracrine Function and Attenuate Lipopolysaccharide-Induced Inflammatory and Oxidative Damage in Pulmonary Microvascular Endothelial Cells.
    Chen X; Zhang Y; Wang W; Liu Z; Meng J; Han Z
    Cell Physiol Biochem; 2018; 49(1):101-122. PubMed ID: 30153667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.